Magnetic Molecular Energizing (MME) is an investigational treatment modality for various types of medical problems. These include particularly neurologic (brain, spinal cord and nerves), orthopedic (bone and joint) disorders and certain cardiac and pulmonary disorders. MME treatment is considered investigational and is utilized under the direction and auspices of an Investigational Review Board (IRB). The IRB complies with FDA requirements for investigational therapy usage and results review. This IRB consists of independent expert physicians and other health professionals who determine the specific treatment protocols and review records and results.

MME therapy is safe and non-invasive. In some cases, patients may experience some tingling, however, most experience no ill effects and can talk, sleep, read or watch TV.

The treatment plan for each patient will vary dependent on the individual and the problem treated. Treatment durations may also vary between a few hours (8-10) to several hundred (200-300) hours. The benefit is additive.  However, treatment results are best if treatment continues, uninterrupted, until maximum results are obtained.  Treatment should occur on a consecutive daily basis.

Although no absolute assurances can be given, there is good reason for optimism of benefit, in individuals who are accepted for treatment. MME enhances and promotes healing of tissues at the cellular and molecular level.